There were 1,640 press releases posted in the last 24 hours and 414,016 in the last 365 days.

Attis Industries Granted 180-Day Extension to Comply with NASDAQ’S Minimum Bid Price Requirement

 A Top Priority to Maintain NASDAQ Listing

MILTON, GA, Oct. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Attis Industries, Inc. (NASDAQ: ATIS) (the “Company” or “Attis”), a diversified company focused on innovation and technology throughout key components of the new economy, which include renewable fuels, bio-based plastics, healthcare and communications infrastructure, today announced that NASDAQ has granted the Company a 180-day extension to comply with NASDAQ’S minimum bid price requirement.

Attis Chief Executive Officer Jeff Cosman, commented, “Just as I discussed last week on our shareholders update call, we are thrilled to have received this extension from NASDAQ as it is of the utmost importance to our Board and management team to remain on NASDAQ.”

Attis Industries, Inc.
Attis Industries Inc. (NASDAQ: ATIS) is a holding company focused on developing and building businesses that play important roles in the new economy, which include renewable fuels, bio-based plastics, healthcare and communications infrastructure. We strive to encourage our employees to be entrepreneurs focused on innovation and technology.  We will remain dynamic, persistent and motivated to our mission of winning.  The growth of our company will rely on our integrity and our vision for the future. Attis Industries will continue to fulfill essential needs in healthcare, energy independence and digital communications.  Today, each of these sectors provide high growth opportunities that collectively account for more than a third of our nations GDP.    For more information, visit: www.attisind.com

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to continue to meet the listing requirements of NASDAQ; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company’s go-forward business, and the risks identified and discussed under the caption “Risk Factors” in the Attis Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2018 and the other documents Attis files with the SEC from time to time. There will be events in the future, however, that Attis is not able to predict accurately or control. Attis’s actual results may differ materially from the expectations that Attis describes in its forward-looking statements. Factors or events that could cause Attis’s actual results to materially differ may emerge from time to time, and it is not possible for Attis to accurately predict all of them. Any forward-looking statement made by Attis in this press release speaks only as of the date on which Attis makes it. Attis undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Media and Investors Contact:
Hayden IR
(917) 658-7878
hart@haydenir.com

Attis.png